Get the Stockscreener App
9.095
7.14%
-0.645
Engene Holdings Inc stock is traded at $9.095, with a volume of 490.29K.
It is down -7.14% in the last 24 hours and up +2.09% over the past month.
enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
See More
Previous Close:
$9.74
Open:
$9.65
24h Volume:
490.29K
Relative Volume:
1.63
Market Cap:
$616.97M
Revenue:
-
Net Income/Loss:
$-103.21M
P/E Ratio:
-1.9771
EPS:
-4.6001
Net Cash Flow:
$-26.70M
1W Performance:
-9.82%
1M Performance:
+2.09%
6M Performance:
+74.61%
1Y Performance:
+60.09%
1-Day Range:
$8.97
$9.72
1-Week Range:
$8.97
$10.34
52-Week Range:
$2.65
$12.25
Engene Holdings Inc Stock (ENGN) Company Profile
Name
Engene Holdings Inc
Sector
Industry
Phone
(514) 332-4888
Address
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Compare ENGN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
9.2099 | 652.48M | 0 | -103.21M | -26.70M | -4.6001 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.69 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
765.88 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
726.14 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
323.44 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
290.22 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Initiated | Jefferies | Buy |
| Nov-11-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Feb-18-25 | Initiated | Piper Sandler | Overweight |
| Feb-14-25 | Downgrade | UBS | Buy → Neutral |
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| Nov-27-24 | Initiated | Raymond James | Outperform |
| Nov-18-24 | Initiated | JMP Securities | Mkt Outperform |
| Aug-28-24 | Initiated | Oppenheimer | Outperform |
| Apr-22-24 | Initiated | Wells Fargo | Overweight |
| Apr-15-24 | Initiated | Guggenheim | Buy |
| Mar-28-24 | Initiated | UBS | Buy |
| Mar-08-24 | Initiated | Morgan Stanley | Overweight |
| Feb-20-24 | Initiated | Leerink Partners | Outperform |
View All
Engene Holdings Inc Stock (ENGN) Latest News
Growth Value: Will enGene Holdings Inc stock hit new highs in YEARWeekly Risk Summary & Daily Profit Focused Stock Screening - baoquankhu1.vn
ENGENE HOLDINGS INC C/WTS 31/10/2028 (TO PUR COM) CL A Stock Quote, Share Price, News and Analysis - Longbridge
Trade Report: What analysts say about enGene Holdings Inc Equity Warrant stockWeekly Investment Recap & Fast Gain Stock Tips - baoquankhu1.vn
[EFFECT] enGene Holdings Inc. SEC Filing - Stock Titan
Why is enGene Holdings Inc Equity Warrant stock going upJuly 2025 Macro Moves & Low Risk Growth Stock Ideas - baoquankhu1.vn
enGene (ENGN) Expected to Announce Earnings on Monday - MarketBeat
enGene Holdings Inc. (NASDAQ:ENGN) Short Interest Down 31.5% in February - MarketBeat
enGene Holdings Inc. (NASDAQ:ENGN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Earnings Recap: Is enGene Holdings Inc Equity Warrant stock a value trap2025 Buyback Activity & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
ENGN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
enGene Maps BLA by End-2026, Targets 2027 Launch for Lead NMIBC Therapy at Oppenheimer Conference - Yahoo Finance
ENGN: Detalimogene shows 62% six-month CR rate in NMIBC, with launch targeted for 2027 - TradingView
Market Trends: How does enGene Holdings Inc compare to its peersJuly 2025 Retail & Safe Entry Point Identification - baoquankhu1.vn
Institution Moves: Is enGene Holdings Inc Equity Warrant stock a value trapJuly 2025 Levels & Consistent Growth Stock Picks - baoquankhu1.vn
CEO Moves: Is OCUL subject to activist investor interestMarket Volume Report & Safe Capital Growth Stock Tips - baoquankhu1.vn
ENGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
enGene Holdings Inc. Warrants Stock Forecast Summary - Meyka
Aug Update: What are the analyst revisions for enGene Holdings IncIs FACT stock a good investment in YEARJuly 2025 PostEarnings & Reliable Breakout Forecasts - baoquankhu1.vn
Returns Recap: How does enGene Holdings Inc compare to its peersMarket Movers & Low Risk Entry Point Tips - baoquankhu1.vn
Should I add enGene Holdings Inc. stock to my portfolioJuly 2025 Highlights & Daily Market Momentum Tracking - mfd.ru
enGene to Highlight Genetic Medicine Pipeline at Series of Investor Conferences - TipRanks
enGene to Participate in Upcoming Investor Conferences - FinancialContent
EnGene Files $400 Million Mixed Shelf - marketscreener.com
EnGene Holdings files for mixed shelf of up to $400 million - marketscreener.com
Engene Holdings Files For Mixed Shelf Of Upto $400 Million - TradingView
Jefferies sets a $28 PT for enGene Holdings Inc. (ENGN) - MSN
EnGene extends momentum with another 14% surge on Friday - MSN
Cormorant Asset Management (ENGN) reports 5.97% passive stake in enGene - Stock Titan
Jefferies Sets a $28 PT for enGene Holdings Inc. (ENGN) - Insider Monkey
enGene Holdings Inc. (ENGN) stock news today: Live updates - Bitget
Can enGene Holdings Inc. Equity Warrant lead its sector in growthStop Loss & AI Optimized Trading Strategy Guides - mfd.ru
Aug Intraday: Does NRGU stock benefit from AI growthWall Street Watch & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Should I hold or sell enGene Holdings Inc. Equity Warrant stock in 2025July 2025 Setups & Community Verified Swing Trade Signals - mfd.ru
P500July 2025 Reactions & Reliable Volume Spike Trade Alerts - mfd.ru
Aug Chart Watch: Can Automatic Data Processing Inc deliver alpha2025 Buyback Activity & Safe Entry Zone Tips - baoquankhu1.vn
enGene Holdings Inc. (NASDAQ:ENGN) Short Interest Up 52.2% in January - MarketBeat
What is enGene Holdings Inc. Equity Warrant’s valuation compared to sector2025 Market Overview & Verified Technical Trade Signals - mfd.ru
Does enGene Holdings Inc. Equity Warrant meet Warren Buffett’s criteria2025 Trade Ideas & Weekly Chart Analysis and Trade Guides - mfd.ru
10 Best Low Volatility Canadian Stocks to Buy - Insider Monkey
Can enGene Holdings Inc Equity Warrant lead its sector in growthJuly 2025 Catalysts & Consistent Profit Trade Alerts - baoquankhu1.vn
Can enGene Holdings Inc. Equity Warrant grow without external fundingJuly 2025 Weekly Recap & Verified Trade Idea Suggestions - mfd.ru
EnGene Holdings Inc (ENGN) surging after positive phase 2 LEGEND trial - MSN
enGene CEO Talks Detalimogene for Community Urology as LEGEND Study Hits Full Enrollment - MarketBeat
Why is enGene Holdings Inc. stock going up2025 Price Momentum & Free Low Drawdown Momentum Trade Ideas - mfd.ru
Will enGene Holdings Inc. stock hit new highs in YEARJuly 2025 Price Swings & Daily Growth Stock Investment Tips - mfd.ru
US Market Recap: Can PACB sustain its profitabilityJuly 2025 Chart Watch & Safe Entry Point Alerts - baoquankhu1.vn
S P Trends: Will enGene Holdings Inc stock hit new highs in YEARDividend Hike & Weekly Market Pulse Updates - baoquankhu1.vn
Levels Update: Will enGene Holdings Inc stock benefit from M AJuly 2025 Rallies & Expert Approved Trade Ideas - baoquankhu1.vn
enGene CEO to Highlight Genetic Medicine Strategy at Guggenheim Biotech Summit 2026 - The Globe and Mail
enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - BioSpace
enGene to Spotlight Bladder Cancer Gene Therapy at Guggenheim Biotech Summit 2026 - TipRanks
Engene Holdings Inc Stock (ENGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):